European Medicines Agency
regulator
| European Medicines Agency link () Campfire Wiki Twitter Website | |
|---|---|
| File:European Medicines Agency.svg | |
| Status | captured |
| Headquarters | Amsterdam, The Netherlands |
| Issued guidance that chloroquine and hydroxychloroquine were only to be used in clinical trials or emergency use programs. | |
The European Medicines Agency (EMA) is an agency of the European Union in charge of the evaluation and supervision of medicinal products. It is the European Union’s equivalent to the Food and Drug Administration (FDA) in the United States.
Prior to 2004, it was known as the European Agency for the Evaluation of Medicinal Products or European Medicines Evaluation Agency.
COVID-19
On 1 April 2020, the EMA issued guidance that chloroquine and hydroxychloroquine are only to be used in clinical trials or emergency use programs.[1] On 29 May 2020, the EMA stated that patients already taking chloroquine for unrelated conditions, should continue to do so, always under the supervision of their doctor.[2]
On 9 December 2020, the EMA was hit with a cyberattack that resulted in the capturing of "[m]ore than 40 megabytes of classified information from the agency’s review" of the Pfizer-BioNTech COVID-19 vaccine.[3][4] These materials were subsequently published to the dark web and sent directly to a number of journalists and academics.
References
- ↑ https://www.ema.europa.eu/en/news/covid-19-chloroquine-hydroxychloroquine-only-be-used-clinical-trials-emergency-use-programmes
- ↑ https://www.ema.europa.eu/en/news/covid-19-reminder-risks-chloroquine-hydroxychloroquine%7C
- ↑ Cyberattack on the European Medicines Agency. (2020, December 9). European Medicines Agency. http://archive.today/2022.09.02-121240/https://www.ema.europa.eu/en/news/cyberattack-european-medicines-agency
- ↑ Tinari, S. (2021). The EMA covid-19 data leak, and what it tells us about mRNA instability. BMJ, n627. https://doi.org/10.1136/bmj.n627
